My watch list


Drug development: Nature-derived peptides as molecular tools to study cellular signalling

19-Dec-2019: A group of researchers of the Institute of Pharmacology at the Medical University of Vienna in collaboration with the University of Vienna and different institutions in Australia, has shown that a certain peptide hormone derived from a mite activates selectively a specific secondary messenger molecule on the human vasopressin 2 receptor (V2R).

This is all the more astonishing since drugs normally activate several different molecular signalling pathways via this class of receptors – belonging to the group of G protein-coupled receptors. This evokes desirable, but also adverse effects. Such peptides can now be used as chemical tools to gain a better understanding of the mechanisms of signal transmission in cells, hence facilitating the more targeted use of drugs in the future – with fewer side-effects.

"The results of our study show that peptides isolated from arthropods are highly suitable for the exploration of targeted, molecular tools or drugs for this class of human receptors," says Principal Investigator Christian Gruber from MedUni Vienna’s Institute of Pharmacology. Around 30% of all drugs act on the so-called G protein-coupled receptors, but various molecular signalling pathway are activated in the cell simultaneously, and not selectively, which, in rare cases, can lead to fatal side-effects. Gruber: "An example of this would be respiratory depression after using opiates for pain control, which is currently a major problem in the USA, known as ‘opiate crisis’."  

However, the Viennese scientists (largely due to the contribution of the two PhD students Edin Muratspahić and Leopold Dürrauer) now seem to have discovered a possible way of using drugs more specifically and stopping non-selective activation of the signalling pathways, namely with peptide hormones derived from Nature – in this case from a mite – that act specifically on a signalling pathway of the human vasopressin 2 receptor (V2R).

Vasopressin-like drugs for example are used in the clinic to treat diabetes insipidus. This condition is characterized by the large amount of dilute urine which is excreted via the kidneys, either because the vasopressin hormone is no longer being produced or the vasopressin receptor in the renal tubules is no longer functional, so that the filtered water cannot be returned to the body. Other applications are, e.g. enuresis or particular forms of haemophilia. "In the future, it might be possible to use synthetically optimised peptide hormones to treat diseases very specifically and eliminate adverse side-effects.", says Gruber.

Exploring evolution & Nature's blueprints

"And all this with the aid of naturally occurring peptides from animal venoms, insect hormones, fungi or plants, which are based on evolution and some of which have evolved over millions of years, to act as defence or messenger substances on similar receptors. This means that we can skip many of the synthesis steps normally required in drug development via combinational chemistry. We are directly using the blueprints of Nature, which has preselected the drug candidates for us so that we can develop optimised signalling molecules and potential drug candidates," explains Gruber.

Multiple sclerosis: Plant peptide a highly promising medication

This is also the basis for this research group's highly promising research in the battle against Multiple Sclerosis (MS). A few years ago, they were able to show in an animal experiment that, following administration of a special synthetically recreated plant peptide (cyclotide), there was no further development of the usual clinical signs of multiple sclerosis. This discovery offers hope that the disease can be halted at a very early stage or, at the very least, its progression can be greatly retarded.

In the meantime, the Swedish company Cyxone has conducted a successful Phase I trial with the drug candidate T20K. However, further clinical trials will be required before the potential approval of the drug and its availability to patients.

Original publication:
"I8-arachnotocin – an arthropod-derived G protein-biased ligand of the human vasopressin V2 receptor"; L. Duerrauer, E. Muratspahić, J. Gattringer, P. Keov, H.C. Mendel, K.D.G. Pfleger, M. Muttenthaler, C.W. Gruber; Scientific Reports
"Nature-Derived Peptides: A Growing Niche for GPCR Ligand Discovery"; E. Muratspahić, M. Freissmuth, C.W. Gruber; Trends in Pharmacological Sciences

Facts, background information, dossiers

  • peptide hormones
  • G protein coupled receptors

More about Medizinische Uni Wien

  • News

    High-fat maternal diet can cause brain damage in the unborn child

    A study team at MedUni Vienna’s Center for Brain Research has found that high-fat maternal diets can cause life-long changes in the brain of the unborn offspring. When a pregnant woman consumes a diet high in polyunsaturated omega-6 fatty acids, her body produces an excess of endogenous can ... more

    The lungs never forget

    According to a current study of the Medical University Vienna, specialised T memory lymphocytes in the lungs that react to inhaled allergens, cause attacks of allergic asthma. These T-helper 2-tissue resident memory cells, which are located in the lungs for a lifetime are known as Th2-TRMs, ... more

    When changing one atom makes molecules better

    The development and improvement of pharmaceuticals plays the central role in the ongoing battle against human disease. Organic synthesis is the field that enables these developments as it offers the toolbox to diversify chemical structures. The group of Nuno Maulide, recently named the Scie ... more

q&more – the networking platform for quality excellence in lab and process

The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.

> more about q&more

q&more is supported by:


Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE